Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
New to MyHealth?
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. You can message your clinic, view lab results, schedule an appointment, and pay your bill.
ALREADY HAVE AN ACCESS CODE?
DON'T HAVE AN ACCESS CODE?
NEED MORE DETAILS?
MyHealth for Mobile
NCCN Guidelines Insights: Melanoma: Cutaneous, Version 2.2024.
NCCN Guidelines Insights: Melanoma: Cutaneous, Version 2.2024. Journal of the National Comprehensive Cancer Network : JNCCN Swetter, S. M., Johnson, D., Albertini, M. R., Barker, C. A., Bateni, S., Baumgartner, J., Bhatia, S., Bichakjian, C., Boland, G., Chandra, S., Chmielowski, B., DiMaio, D., Dronca, R., Fields, R. C., Fleming, M. D., Galan, A., Guild, S., Hyngstrom, J., Karakousis, G., Kendra, K., Kiuru, M., Lange, J. R., Lanning, R., Logan, T., Olson, D., Olszanski, A. J., Ott, P. A., Ross, M. I., Rothermel, L., Salama, A. K., Sharma, R., Skitzki, J., Smith, E., Tsai, K., Wuthrick, E., Xing, Y., McMillian, N., Espinosa, S. 2024; 22 (5): 290-298Abstract
The NCCN Guidelines for Cutaneous Melanoma (termed Melanoma: Cutaneous) provide multidisciplinary recommendations for diagnostic workup, staging, and treatment of patients. These NCCN Guidelines Insights focus on the update to neoadjuvant systemic therapy options and summarize the new clinical data evaluated by the NCCN panel for the recommended therapies in Version 2.2024 of the NCCN Guidelines for Cutaneous Melanoma.
View details for DOI 10.6004/jnccn.2024.0036
View details for PubMedID 39019054